15:18 IST
NSE
Management Change
Fortis Healthcare Management Change
Fortis Healthcare announced the appointment of Mr. Vijender Singh as MD and CEO of its subsidiary, Agilus Diagnostics, effective July 20, 2026.
Fortis Healthcare Ltd
- Share price
- ₹774.90
- Market cap
- ₹58,502 Cr
- Revenue (annual)
- ₹9,128 Cr
- Net profit (annual)
- ₹1,042 Cr
- P/E (TTM)
- 55.8×Sector 53.1×
- Promoter holding
- 31.17%+0.00% QoQ
- FII holding
- 25.20%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Legal & Regulatory 3Other Announcement 2Management Change 2Earnings Call 2Board Meeting Outcome 2Annual General Meeting 2Results Update 1Partnership 1Merger & Restructuring 1Financial Results 1Dividend 1Board Meeting Date 1
Time
2 announcements with these filters
11:04 IST
BSE
Management Change
Fortis Healthcare Management Change
Fortis Healthcare re‑appoints Dr. Ashutosh Raghuvanshi as CEO effective 19‑Mar‑2027 for a 24‑month term. The change was approved in the board meeting on 8‑Jul‑2026.